Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
Bandhan Healthcare Fund Direct Growth
NAV: 11 Sep '26
₹11.43
Min. for SIP
₹100
Fund size (AUM)
₹331.57 Cr
Expense ratio
1.31%
Rating
--
Return calculator
Monthly investment
₹5,000
| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 3 months | ₹15,000 | ₹15,385 | +2.57% | |
| 6 months | ₹30,000 | ₹32,850 | +9.50% |
Holdings (38)
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.48% |
| Cipla Ltd | Healthcare | Equity | 6.38% |
| Max Healthcare Institute Ltd | Healthcare | Equity | 5.81% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 5.64% |
| Reverse Repo | Unspecified | Reverse Repo | 4.33% |
| Divi's Laboratories Ltd | Healthcare | Equity | 4.28% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 4.14% |
| Lupin Ltd | Healthcare | Equity | 3.96% |
| Shilpa Medicare Ltd | Healthcare | Equity | 3.72% |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | Equity | 3.68% |
| Dr. Reddy's Laboratories Ltd | Healthcare | Equity | 3.48% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 3.36% |
| Gland Pharma Ltd | Healthcare | Equity | 3.05% |
| Zydus Lifesciences Ltd | Healthcare | Equity | 2.78% |
| Narayana Hrudayalaya Ltd | Healthcare | Equity | 2.59% |
| Global Health Ltd | Healthcare | Equity | 2.45% |
| Syngene International Ltd | Healthcare | Equity | 2.42% |
| Eris Lifesciences Ltd | Healthcare | Equity | 2.35% |
| Glenmark Pharmaceuticals Ltd | Healthcare | Equity | 2.24% |
| Rainbow Childrens Medicare Ltd | Healthcare | Equity | 2.13% |
| Pfizer Ltd | Healthcare | Equity | 1.84% |
| Ajanta Pharma Ltd | Healthcare | Equity | 1.74% |
| Healthcare Global Enterprises Ltd | Healthcare | Equity | 1.66% |
| Sanofi India Ltd | Healthcare | Equity | 1.51% |
| Novartis India Ltd | Healthcare | Equity | 1.50% |
| Ipca Laboratories Ltd | Healthcare | Equity | 1.49% |
| Thyrocare Technologies Ltd | Healthcare | Equity | 1.46% |
| Jubilant Pharmova Ltd | Healthcare | Equity | 1.46% |
| Glenmark Life Sciences Ltd | Healthcare | Equity | 1.36% |
| Astrazeneca Pharma India Ltd | Healthcare | Equity | 1.26% |
| Sai Life Sciences Ltd. | Healthcare | Equity | 1.10% |
| Orchid Pharma Ltd | Healthcare | Equity | 1.08% |
| Sai Parenteral’s Ltd. | Healthcare | Equity | 0.95% |
| Medi Assist Healthcare Services Ltd. | Industrials | Equity | 0.89% |
| Dr. Lal Pathlabs Ltd | Healthcare | Equity | 0.88% |
| Sequent Scientific Ltd | Healthcare | Equity | 0.85% |
| Others Mrgn Money | Unspecified | Margin Money | 0.03% |
| Net Payables | Unspecified | Net Payables | -0.33% |
See All
Minimum investments
Min. for 1st investment
₹1,000
Min. for 2nd investment
₹1,000
Min. for SIP
₹100
Returns and rankings
Annualised returns
Absolute returns
| Name | 1M | 3M | 6M | All |
|---|---|---|---|---|
| Fund returns | -0.0% | +10.8% | +17.1% | +14.3% |
| Category average (Equity Sectoral) | -- | -- | -- | -- |
| Rank (Equity Sectoral) | -- | 9 | 15 | -- |
Exit load, stamp duty and tax
Exit load
Exit load of 0.50%, if redeemed within 30 days.
Stamp duty on investment: 0.005% (from July 1st, 2020)
from July 1st 2020
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Check past data
Fund management
BSBrijesh ShahNov 2025 - PresentView details
BS
Brijesh Shah
Nov 2025 - Present
View details
VKViraj KulkarniNov 2025 - PresentView details
VK
Viraj Kulkarni
Nov 2025 - Present
View details
RBRitika BeheraNov 2025 - PresentView details
RB
Ritika Behera
Nov 2025 - Present
View details
GSGaurav SatraNov 2025 - PresentView details
GS
Gaurav Satra
Nov 2025 - Present
View details
About Bandhan Healthcare Fund Direct Growth
Bandhan Healthcare Fund Direct Growth is a Equity Mutual Fund Scheme launched by Bandhan Mutual Fund. This scheme was made available to investors on 20 Dec 1999. Brijesh Shah is the Current Fund Manager of Bandhan Healthcare Fund Direct Growth fund. The fund currently has an Asset Under Management(AUM) of ₹2,20,143 Cr and the Latest NAV as of 11 Sep 2026 is ₹11.43.
The Bandhan Healthcare Fund Direct Growth is rated Very High risk. Minimum SIP Investment is set to ₹100. Minimum Lumpsum Investment is ₹1,000. Exit load of 0.50%, if redeemed within 30 days.
;
Investment Objective
The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors.
Fund benchmarkBSE Healthcare Total Return Index
Fund house
Rank (total assets)#9 in India
Total AUM₹2,20,142.95 Cr
Date of Incorporation20 Dec 1999
Launch Date20 Dec 1999
AddressOne World Centre, 6th Floor, Tower 1C,Senapati Bapat Marg, Prabhadevi Mumbai 400013
Websitewww.camsonline.com
Address7th Floor, Tower II, Rayala Towers, 158, Anna Salai,